Pipeline of Drug Candidates

Billing Xpress is developing drug candidates for expanding market segments with high unmet need.

Preclinical

Phase 1

Phase 2

Phase 3

Hepatitis B

Phase 2a

55%

Hepatitis B

Advancing into IND-Enabling Studies

20%

Post-herpetic Neuralgia (PHN)

Phase 3

85%